InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Auster Martin. Officer active across 1 company, notably Ventyx Biosciences, Inc.. In total, 10 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €3.2m. History available since 2 December 2022. The latest transaction was filed on 2 April 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Auster Martin is Chief Financial Officer at Ventyx Biosciences, Inc. He has 10 filings in total. Across the 10 recent filings we hold, they cover the period from 2022-12-06 to 2024-04-03, with 0 in buys and 3,248,645 in sells, and the most common transaction nature is Exercise of options.